Search Results Search Sort by RelevanceMost Recent Policy Forum Apr 2006 Infectious Disease Research and Dual-Use Risk Maureen Kelley, PhD Virtual Mentor. 2006;8(4):230-234. doi: 10.1001/virtualmentor.2006.8.4.pfor1-0604. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. AMA Code Says Sep 2004 Physician-Scientists and Social Responsibility Shane K. Green, PhD Virtual Mentor. 2004;6(9):416-419. doi: 10.1001/virtualmentor.2004.6.9.code1-0409. Case and Commentary May 2016 Consequences for Patients and Their Loved Ones When Physicians Refuse to Participate in Ethics Consultation Processes David S. Seres, MD, ScM While some physicians try to avoid ethics consultations, their participation can be essential for good patient care. AMA J Ethics. 2016;18(5):493-498. doi: 10.1001/journalofethics.2016.18.5.ecas3-1605. Viewpoint Jan 2012 An Ethical Take on the "Stress Vaccine" Jennifer M. Ladd and Leo D. J. Ungar, MTS Concerns about the deleterious effects of stress on the mind and body have led to the beginnings of a stress vaccine, an injection that will reduce these effects. Virtual Mentor. 2012;14(1):60-67. doi: 10.1001/virtualmentor.2012.14.1.oped2-1201. Case and Commentary Feb 2013 Profiling Patients to Identify Prospective Donors Richard E. Thompson, MD If wealth screening and patient care must be mixed, they would be safer and more effective if guided by a policy developed with input from physicians. Virtual Mentor. 2013;15(2):114-118. doi: 10.1001/virtualmentor.2013.15.2.ecas3-1302.
Policy Forum Apr 2006 Infectious Disease Research and Dual-Use Risk Maureen Kelley, PhD Virtual Mentor. 2006;8(4):230-234. doi: 10.1001/virtualmentor.2006.8.4.pfor1-0604.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
AMA Code Says Sep 2004 Physician-Scientists and Social Responsibility Shane K. Green, PhD Virtual Mentor. 2004;6(9):416-419. doi: 10.1001/virtualmentor.2004.6.9.code1-0409.
Case and Commentary May 2016 Consequences for Patients and Their Loved Ones When Physicians Refuse to Participate in Ethics Consultation Processes David S. Seres, MD, ScM While some physicians try to avoid ethics consultations, their participation can be essential for good patient care. AMA J Ethics. 2016;18(5):493-498. doi: 10.1001/journalofethics.2016.18.5.ecas3-1605.
Viewpoint Jan 2012 An Ethical Take on the "Stress Vaccine" Jennifer M. Ladd and Leo D. J. Ungar, MTS Concerns about the deleterious effects of stress on the mind and body have led to the beginnings of a stress vaccine, an injection that will reduce these effects. Virtual Mentor. 2012;14(1):60-67. doi: 10.1001/virtualmentor.2012.14.1.oped2-1201.
Case and Commentary Feb 2013 Profiling Patients to Identify Prospective Donors Richard E. Thompson, MD If wealth screening and patient care must be mixed, they would be safer and more effective if guided by a policy developed with input from physicians. Virtual Mentor. 2013;15(2):114-118. doi: 10.1001/virtualmentor.2013.15.2.ecas3-1302.